Skip to main content
Amyotrophic Lateral SclerosisDiagnostics and screeningRare diseaseHealthy volunteers

What this study is

The purpose of the study is to determine if we are able to find one or more biomarkers of Amyotrophic Lateral Sclerosis (ALS) and Primary Lateral Sclerosis (PLS) using magnetic resonance imaging (MRI) scans at different levels, 3 tesla (3T) and 7 tesla (7T). A biomarker is a measurable characteristic that can be used as an indicator of a particular disease state. Identifying biomarkers of a disease can lead to a better understanding of the disease as well as improved treatments. This study will enroll patients with ALS, PLS, and healthy controls.

Study details

Official title
A Longitudinal Study of Imaging Biomarkers in Amyotrophic Lateral Sclerosis (ALS)
Sponsor
University of Minnesota
Conditions
Amyotrophic Lateral Sclerosis · Primary Lateral Sclerosis
Enrolling
30 people
Starts
2015-09
Est. completion
2031-09-30
Record
View on ClinicalTrials.gov ↗